Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $113.0800 (-1.02%) ($112.0900 - $116.7400) on Wed. May. 13, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.83% (three month average) | RSI | 59 | Latest Price | $113.0800(-1.02%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR advances 1.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(36%) IBB(31%) XBI(31%) VFMO(30%) VYM(30%) | Factors Impacting UTHR price | UTHR will decline at least -1.915% in a week (0% probabilities). VIXM(-21%) VXX(-16%) UUP(-11%) TLT(-6%) XLC(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.915% (StdDev 3.83%) | Hourly BBV | 0 () | Intraday Trend | -0.8% | | | |
|
5 Day Moving Average | $113.68(-0.53%) | 10 Day Moving Average | $112.45(0.56%) | 20 Day Moving Average | $109.94(2.86%) | To recent high | -2.2% | To recent low | 42.4% | Market Cap | $5.016b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |